Selective Chk1 inhibitors differentially sensitize p53‐deficient cancer cells to cancer therapeuticsZehan Chen, Haiying Zhang|International Journal of Cancer|2006Cited by 129
Differential roles of checkpoint kinase 1, checkpoint kinase 2, and mitogen-activated protein kinase–activated protein kinase 2 in mediating DNA damage–induced cell cycle arrest: implications for cancer therapyZhan Xiao, Haiying Zhang|Molecular Cancer Therapeutics|2006Cited by 94
Optimization of ultracentrifugation‐based method to enhance the purity and proteomic profiling depth of plasma‐derived extracellular vesicles and particlesZurong Wan, Haiying Zhang|Journal of Extracellular Biology|2024Cited by 6